We performed ChIP-seq in three human luminal breast cancer cell lines and three human basal A breast cancer cell lines and identified 6527 shared GRHL2 binding sites in all luminal and 13,351 shared GRHL2 binding sites in all basal A cell lines (Figure 3A). Here, GRHL2 is linked to breast carcinoma.